Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma a study by in situ hybridization with biotinylated DNA probes
β Scribed by Anette Lynge Nielsen
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 571 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Among 345 lesions histologically defined as cervical intraepithelial neoplasia (CIN) examined by in situ hybridization (ISH) for the presence of DNA from human papillomavirus (HPV) types 6/11, 16, 18, 31, 33, and 51, a group of 69 lesions (41 low grade and 28 high grade) containing HPV 16 or 18 was
## Abstract The primary objective of this report is to describe the detection of adenocarcinoma __in situ__ (AIS) and associated human papillomavirus (HPV) type distribution that was observed in the context of two phase 3 clinical trials of a quadrivalent HPV6/11/16/18 vaccine. In this intentionβto
Paclitaxel is a recent chemotherapeutic agent that inhibits tubulin depolymerization in tumoral cells. Despite its increasing use against various human cancers, the genotoxicity of paclitaxel has never been studied on normal human cells. The in vitro genotoxic effects of the drug were evaluated with